Form 4: Clearmind Medicine Inc. Insider Trading Activity

HRT FINANCIAL LP reports significant transactions in Clearmind Medicine Inc. common stock.

Summary

• HRT FINANCIAL LP, identified as a 10% owner and director of Clearmind Medicine Inc. (CMND), has reported transactions related to the company's common stock.
• On June 15, 2026, HRT FINANCIAL LP acquired 3,183 shares of common stock at a price of $3.32 per share.
• Following this transaction, HRT FINANCIAL LP beneficially owns 103,492 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it indicates continued investment by a key insider, but does not provide new strategic or financial information.

Positives

• HRT FINANCIAL LP, a significant stakeholder, has increased its direct beneficial ownership of Clearmind Medicine Inc. common stock.
• The acquisition of 3,183 shares at $3.32 per share indicates continued investment by a key insider.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are crucial for understanding insider activity, which can provide insights into management's confidence in the company's prospects. This filing details a direct purchase of common stock by a significant 10% owner and director.

Stakeholder Impact

• Shareholders may view the increased direct ownership by a 10% owner and director as a positive signal of confidence in the company.

Key Dates

Keywords

SEC Form 4, Insider Trading, Beneficial Ownership, Clearmind Medicine Inc., CMND, HRT FINANCIAL LP, Common Stock, Securities Exchange Act